Crossref
PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel
Clinical Ovarian Cancer · 2011
DOI: 10.1016/j.cloc.2012.02.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Ovarian Cancer, 2011. Verfasst von Krishnansu S. Tewari. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tewari, K. S. (2011). PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. https://doi.org/10.1016/j.cloc.2012.02.014
Vancouver
Tewari KS. PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel. Clinical Ovarian Cancer. 2011. doi:10.1016/j.cloc.2012.02.014
BibTeX
@article{Tewari2011,
author = {Tewari, Krishnansu S.},
title = {PRO: Patients With Metastatic/Recurrent Cervical Cancer Should be Treated With Cisplatin Plus Paclitaxel},
journal = {Clinical Ovarian Cancer},
year = {2011},
doi = {10.1016/j.cloc.2012.02.014}
}
EUVIMED